Skip to content
RxMonitor home

Medication

Pamidronate Disodium for Injection

DIN 02246597 · Fresenius Kabi Canada Ltd Likely a generic

What it is

Active ingredients
Form and route
Solution · Intravenous
Schedule
PRESCRIPTION
Authorised since
2004-03-01

Source: Health Canada — Drug Product Database. Data current as of 2026-08-12.

Products with the same active ingredient

Grouped by Health Canada’s active-ingredient group number. Products in a group do not always share a strength — check the strength above against your own. Sharing an active ingredient does not mean two products can be substituted for each other: whether a substitution is permitted is a provincial decision, and this page does not show it. Ask a pharmacist.

Ontario Drug Benefit coverage

As of 31 July 2026

Off-formulary interchangeable Part III-B

Ontario has designated this product interchangeable with a brand product, but it is not an ODB benefit — Part III-B, Off-Formulary Interchangeable. Ontario does not pay for it under the benefit list.

It may be funded through the Exceptional Access Program, which needs a patient-specific application from a prescriber and is decided case by case.

What ODB pays per unit
$86.7800

This is what the Ontario Drug Benefit program reimburses a pharmacy for one unit, as of 31 July 2026. A deductible and a co-payment sit on top of it and differ by program — ODB, the Trillium Drug Program and the seniors co-payment each work differently — so it is not the figure anyone is charged at a counter. It also says nothing about private, workplace or federal coverage.

Source: Ontario Ministry of Health — ODB Formulary. Data current as of 2026-07-28. Ontario only. Formulary edition 4342, effective 31 July 2026.

How it is classified

Anatomical main group
Musculo-skeletal system
ATC code
M05BA03

The Anatomical Therapeutic Chemical code records the body system a medicine acts on and its chemical grouping. It is not a statement of what this medication treats, and nothing on this page is. For the full classification of M05BA03, see the WHO ATC/DDD Index.

Recalls and safety alerts

Recall matching is not available yet.

RxMonitor does not yet match Health Canada recalls to individual products — that arrives in a later release. Nothing on this page should be read as confirming that this medication has not been recalled.

Search Health Canada recalls for Pamidronate Disodium for Injection

Important:

Information only — this is not medical advice. RxMonitor shows what Health Canada and provincial drug programs have published about authorised products. It does not tell you what to take, whether a medication is right for you, or what dose to use.

Always talk to a pharmacist or physician about your own medication, and never start, stop or change one based on what you read here.